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Abstract Dynein heavy chains (DHCs) are the main compo-
nents of multisubunit motor ATPase complexes called dyneins. 
Axonemal dyneins provide the driving force for ciliary and 
flagellar motility. Recent molecular studies demonstrated that 
multiple DHC isoforms are produced by separate genes. We 
describe the isolation of five human axonemal DHC genes. 
Analysis of the human genomic clones revealed the existence of 
intronic sequences that were used to demonstrate that human 
axonemal DHC genes are located on different chromosomes. The 
cloned human DHC sequences were integrated into an evolu-
tionary approach based on phylogenetic analysis. Tissue expres-
sion studies showed that these human axonemal DHCs are 
expressed in testis and/or trachea, two tissues with axonemal 
structures that can be altered in primary ciliary dyskinesia, 
making DHC genes strong candidates in the genesis of these 
human diseases. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Dynein heavy chains (DHC) are high-molecular-weight 
( > 400 kDa) microtubule-dependent motor ATPases respon-
sible for many types of cell motility. Although they are func-
tionally similar to kinesin and myosin as regards the general 
mechanism coupling the energy of ATP hydrolysis to the pro-
duction of mechanical force, they are structurally distinct. 
DHCs belong to large multisubunit complexes ( > 1000 kDa), 
the dyneins, that contain DHCs (400-500 kDa), intermediate 
chains (45-110 kDa) and light chains (8-55 kDa) [1,2]. Two 
major classes of dyneins have been identified, the axonemal 
and cytoplasmic dyneins. The cytoplasmic dynein isoforms are 
involved in a relatively wide range of intracellular functions, 
including retrograde vesicle transport, positioning of some 
organelles (e.g. Golgi apparatus) and chromosome movements 
on the mitotic spindle [3]. In ciliary and flagellar axonemes, 
the axonemal dyneins are components of the outer and inner 
dynein arms attached to the peripheral microtubule doublets. 
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While only two cytoplasmic DHC isoforms have been de-
scribed in sea urchins, rats and humans, the composition of 
axonemal dyneins is more complex. Immunological studies 
and genetic analyses of Chlamydomonas reinhardtii mutants 
with defective flagellar motility suggested the existence of a 
multigene DHC family [4-9]. This hypothesis has been con-
firmed by the determination of full-length coding cDNA se-
quences (about 12000-15 000 bp encoding 4000-5000 amino 
acids) and partial cDNA or genomic sequences encoding cy-
toplasmic and axonemal DHCs in various species. Regarding 
axonemal DHCs, three full-length coding sequences have been 
cloned: the sea urchin [3 DHC [10,11] and the Chlamydomonas 
P and y DHCs [12,13]. In addition, several partial axonemal 
DHC sequences have been identified in Chlamydomonas 
[13,14] P. tetraurelia [15], D. melanogaster [16], sea urchins 
[17], rats [18,19] and very recently in humans [20]. Phylo-
genetic studies suggest that the DHC gene family comprises 
at least fifteen members, two cytoplasmic DHC genes and at 
least thirteen axonemal DHC genes [17]. Comparison of the 
predictive amino acid sequences deduced from complete cod-
ing sequences revealed highly conserved polypeptide domains. 
The central third of DHCs contains the catalytic domain of 
the protein which is the most highly conserved region with 
four P-loop consensus motifs involved in nucleotide binding 
(GXXXXGKT/S/Q) [21]. 
In humans, axonemal ultrastructural abnormalities have 
been described in several patients with a congenital respira-
tory disease known as primary ciliary dyskinesia, which in-
cludes Kartagener's syndrome [22]. As defects in axonemal 
DHCs could therefore underlie those genetic disorders, we 
designed a cloning strategy, based on the conservation of 
the first P-loop region (PI-loop), to explore the diversity of 
the human DHC gene family. 
2. Materials and methods 
2.1. Alignment of nucleotide sequences and primer design 
Fifty-six nucleotide sequences encoding the PI-loop region of var-
ious species were aligned by using the ClustalW program [23] with 
default parameters. We analysed data released from the GenBank 
data base for cytoplasmic DHCs from rats [24,25], humans [26], 
D. discoideum [27], yeast [28,29], E. nidulans [30], N. crassa [31], 
P. tetraurelia [15], C. elegans [32], D. melanogaster [33] and sea urchins 
[17], and for axonemal DHCs from rats [18], P. tetraurelia [15], 
C. reinhardtii [12,13], D. melanogaster [16] and sea urchins [17]. The 
oligonucleotide primers for PCR were designed according to the ami-
no acid sequences corresponding to the most conserved regions of the 
PI-loop domain among the cytoplasmic or axonemal DHC sequences, 
and to compensate for the potential mismatches between templates 
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Fig. 1. Schematic representation of the seven primers synthesized for PCR amplification. The four centrally located P-loops are indicated by 
boxes 1^1 on a whole dynein heavy chain depicted by black bar, box 1 (hatched box) being the catalytic functional Pl-loop. Arrows indicate 
the locations and directions corresponding to the primers (S1-S4 and A1-A3), whose sequences are described in Table 1. 
and primers. Four sense (SI, S2, S3 and S4) and three antisense (Al, 
A2 and A3) degenerate or specific primers were synthesized; their 
positions and nucleotide sequences are shown in Fig. 1 and Table 1, 
respectively. 
2.2. PCR conditions, subcloning, and sequencing 
Human genomic DNA (500 ng) was diluted into a reaction volume 
of 50 JJ.1 containing 100 pmols of each primer, 200 mM each dNTP, 
5 ul of 10 X PCR buffer and 0.5 unit of Taq polymerase (ATGC 
Biotechnologies, Noisy-le-Grand, France). After initial denaturation 
for 5 min at 94°C, amplification conditions were 30 cycles of 1 min at 
94°C, 1 min at 58°C and 1.5 min at 72°C, followed by a final exten-
sion for 7 min at 72°C. Amplification products were analysed by 
electrophoresis on a 1% agarose gel (Life Technologies) stained with 
ethidium bromide. PCR products were subcloned into the vector 
pTAg by using the LigATor cloning kit following the manufacturer's 
instructions (R and D systems Europe Ltd, Abingdon, UK). The 
plasmids were purified using the QIAquick PCR purification kit (Qia-
gen). Fluorescence sequencing was performed in a Perkin-Elmer Ap-
plied Biosystem Model 373A instrument using an ABI PRISM dye 
terminator cycle sequencing ready reaction kit with AmpliTaq FS 
DNA polymerase (Perkin Elmer). Each plasmid was sequenced on 
both strands with Ml3-20 and M13-RP sequencing primers. 
2.3. Chromosomal location by somatic cell hybrid analysis 
The chromosomal location of the cloned products was determined 
by using DNA from NIGMS human X rodent somatic cell hybrid 
mapping panel 2 (Coriell Institute for Medical Research, Camden, 
NJ) as template. PCR was performed as described above with primers 
located in intronic sequences of the different cloned products (Table 
1). Amplification products were analysed by electrophoresis on 4% 
agarose gels (2% agarose/2%Nusieve) (Life Technologies and FMC 
BioProducts, Rockland, ME) stained with ethidium bromide. 
2.4. Construction of a phylogenetic tree 
The deduced amino acid sequences of the Pl-loop region from yeast 
[28], sea urchins [10,17], rats [18,24] and humans [20,26] were aligned 
with the ClustalW program using the default parameters [23]. This 
alignment was performed using truncated sequences of 43 amino acids 
from 1917 to 1959, referring to rat cytoplasmic amino acid DHC 
sequence [24]. Phylogenetic tree was constructed by the distance ma-
trix method and neighbor-joining (NJ) method [34]. The yeast cyto-
plasmic DHC was arbitrarily used to root the tree based on UPGMA 
analysis. Figures were drawn using the NJ-plot program. 
2.5. Reverse transcriptase-PCR analysis 
Total RNA from several human tissues including adult trachea, 
Table 1 
Sequences of oligonucleotide primers used for amplification reactions 
Primer" Sequence Specificity 
SI 
S2 
S3 
S4 
Al 
A2 
A3 
Sel 
Se2 
Se3 
Se4 
Se5 
Sil 
Ai2 
Si3 
Ai4 
Si5 
Ai6 
Si7 
Ai8 
Si9 
AilO 
Sill 
Ail2 
5'-CTSAAYCTTGGWGGWGCHCCNG-3' 
5'-GGNAARACNGAGACCACCAARGAT-3' 
5'-ACCACCAARGATYTKGSCAARGC-3' 
5'-CGGTTTGTTTTAGTTTTCAAC-3' 
5'-CGGTTGAACTCGTCAAAGCA-3' 
5'-GGATTCATGGTGATGAAGAT-3' 
5'-DCSDCCDGCRTAICCDGGRTTCAT-3' 
5'-CTCTGACCAGCTCGACTTCATGGC-3' 
5'-CTGGGCATATATGTCATTGTGGTC-3' 
5'-GACTTGGCTAAAGCTCTTGCTGTA-3' 
5'-GCAAGACAGAAACCACCAAAGATT-3' 
5'-CGTGCCCTTGGCATGATGGTCTAT-3' 
5'-GCAGCAGCAGCGGGTGAGCC-3' 
5'-GTGGGGAIAGGCTGACTTGC-3' 
5'-GGTCAGTATCCTGCCACCCT-3' 
5'-CAGGCAGAGTCACTGGGGAG-3' 
5'-GGGAAAGGTAGTTAAATTGC-3' 
5'-TTAAAAAAC TAAGGAC AAAG-3' 
5'-CAGGTAAGCAAATGCCATCT-3' 
5'-ACCACACAC TAGAAAG AGGG-3' 
5'-AATGGACTACAAAGTAAGTT-3' 
5'-TATTGCCTATGGACTAAATG-3' 
5'-TTTTAGTGCCTGTGTCTTGG-3' 
5'-GACAAAATAICCACGTGCAA-3' 
axonemal DHC 
axonemal DHC 
axonemal DHC 
cytoplasmic DHC 
cytoplasmic/axonemal DHC 
cytoplasmic/axonemal DHC 
axonemal DHC 
exonic Dnahcl 
exonic Dnahc2 
exonic Dnahc3 
exonic Dnahc3-b 
exonic Dnahcl 1 
intronic Dnahcl 
intronic Dnahcl 
intronic Dnahc2 
intronic Dnahc2 
intronic Dnahc3 
intronic Dnahc3 
intronic Dnahc3-b 
intronic Dnahc3-b 
intronic Dnahcll 
intronic Dnahcll 
intronic Dnchcl 
intronic Dnchcl 
aPrimers are designated with a first letter (S or A) referring to their orientations (sense or antisense, respectively). 
C. Chapelin et al.lFEBS Letters 412 (1997) 325-330 327 
testis, liver and lung was obtained from Clontech. Reverse transcrip-
tion was performed using 10 ug of RNA with Superscript II reverse 
transcriptase (Life Technologies) and 100 ng of hexanucleotides 
(Pharmacia). One-sixth of this material was used as a cDNA template 
in PCR assays with different sets of primers: a specific primer (corre-
sponding to the exonic sequences, Table 1) and a degenerated primer 
(used in the cloning procedure, Table 1). To ensure that cDNA and 
not genomic DNA was amplified, each amplification was performed 
using a primer set that brackets at least one intronic sequence. Am-
plification of the Dnchcl, Dnahcl, Dnahc2, Dnahc3, Dnahc3-b and 
Dnahcll transcripts was performed using the primer sets S4/A2, Sel/ 
A3, Se2/A2, Se3/A3, Se4/Al and Se5/Al, respectively. To check the 
integrity of RNAs, an RT-PCR run was performed with a primer set 
specific for p2microglobulin. Amplification products were analysed by 
electrophoresis on 4% agarose gels (2% agarose/2%Nusieve) (Life 
Technologies and FMC BioProducts, Rockland, ME) stained with 
ethidium bromide. 
3. Results 
3.1. Isolation of human DHC genomic clones 
Amplification of human genomic DNA with primers de-
signed according to the sequences of conserved DHC subdo-
mains, i.e. encoding the PI-loop region, gave rise to PCR 
products which sizes were larger than expected for coding 
sequence, a result pointing to the presence of intronic se-
quences. These PCR products were systematically subcloned. 
Sequence analysis showed that thirty independent clones con-
tained a sequence encoding a consensus motif of the DHC Pl-
loop region. Screening for splice donor and acceptor sites was 
performed to locate potential intronic sequences, based on 
splice junction consensus sequences [35]. We also verified 
that the reading frame across exon boundaries was as ex-
pected; this was indeed the case for all the genomic clones. 
Sequence analysis revealed the existence of six different clones 
containing at least one intron. The insert locations of the 
introns are variable (Fig. 2). 
3.2. Analysis of the nucleotide and deduced amino acid 
sequences of the coding sequence of the six genomic clones 
We aligned the nucleotide and deduced amino acid se-
quences of the coding sequence of the six human clones iso-
lated in this study with cytoplasmic and axonemal human 
DHC cDNA sequences. The coding sequences of three of 
these six clones are identical to DHC sequences recently re-
ported: one is identical to the Dnchcl cytoplasmic DHC 
[20,26,36], two are identical to the Dnahcl and Dnahc3 axon-
emal DHCs (Dnahcl [20], DHC3 [36] which is identical to 
Dnahc3 [20]). The three remaining clones correspond to new 
human DHC sequences and were designated Dnahc2, 
Dnahc3-b and Dnahcll with respect to their homology with 
rat DHC sequences, i.e. DLP2, DLP3 and DLP11 sequences, 
respectively [18]. As human Dnahc3, previously cloned and 
named by Vaughan et al. [20], is actually more homologous 
to rat DLP12 than to rat DLP3, the human clone isolated in 
the present study, that indeed corresponds to rat DLP3 (Figs. 
2 and 3), was designated Dnahc3-b. 
3.3. Chromosomal location 
To define the chromosomal distribution of the identified 
human DHC genes, we took advantage of the intronic nucleo-
tide sequences. For each of the six clones, we designed a 
primer set located in an intron (Table 1). These primer sets 
were used to screen a panel of 24 hybrid somatic cell lines 
(humanEXErodent), each of them retaining one of the 24 
human chromosomes. The Dnchcl, Dnahcl, Dnahc2, Dnahc3 
and Dnahcll genes were found to be located on chromosomes 
14, 3, 17, 3 and 7, respectively (data not shown). Regard-
ing the Dnahc3-b gene, an amplification product of expected 
size and sequence was detected in two somatic hybrid cell 
lines, corresponding to chromosomes 14 and 16 (data not 
shown). 
Dnchcl 
Dnahcl 
Dnahc2 
Dnahc3 
Dnahc3-b 
Dnahcll 
Dnchc2 
Dnahc5 
Dnahc6 
Dnahc9 
Dnahcl 4 
Dnchcl 
Dnahcl 
Dnahc2 
Dnahc3 
Dnahc3-b 
Dnahcll 
Dnchc2 
Dnahc5 
Dnahc6 
Dnahc9 
Dnahcl4 
[S4/A2]* 
[S2/A3]* 
[S3/A2] 
[S1/A3]* 
[Sl/Al] 
[S2/A1] 
(DHC2, Vaisberg 1996) 
(Vaughan 1994) 
(Vaughan 1994) 
(Vaughan 1994) 
(Vaughan 1994) 
[S4/A2]* 
[S2/A3]* 
[S3/A2] 
[S1/A3]* 
[Sl/Al] 
[S2/A1] 
(DHC2, Vaisberg 1996) 
(Vaughan 1994) 
(Vaughan 1994) 
(Vaughan 1994) 
(Vaughan 1994) 
1 60 
DETFDFQAMGRIFVGLCQVGAWGCF 
LGKALAIQTVVFNCSDQLDFMAMGKFFKGLASAGAWACF 
LGIYVIWNCSEGLDYKSMGRMYSGLAQTGAWGCF 
GPAGTGKTETTKDLAKALAVQCWFNCSDGLDYLAMGKFFKGLASSGAWACF 
GPAGTGKTETTKDLAKALAKQCWFNCSDGLDYKAMGKFFKGLAQAGAWA. . 
LGRALGMMVYVFNCSEQMDYKSIGNIYKGLVQTGAWG.. 
MGLGGNPYGPAGTGKTESVKALGGLLGRQVLVFNCDEGIDVKSMGRIFVGLVKCGAWGCF 
MSMGGAPAGPAGTGKTETTKDMGRCLGKDVWFNCSDQMDFRGLGRIFKGLAQSGAWGCF 
LDLGGAPAGPAGTGKTETTKDLAKALAIQCWFNCSDGLDYKMMGRFFSGLAQSGAWGCF 
AGTGKTETTKDLGRALGILVYVFNCSEQMDYKSCGNIYKGLAQTGAWGCF 
PAGTGKTETVKDLAKSLGKHCWFNCFEDLDYKIVRKFFFGLVQSGALGCF 
61 120 
DEFMRLEERMLSAVSQQVQCIQEALREHSNPNYDKTSAPITCELLNKQVKVSPDMA.... 
DEFNRIDIEVLSWSQQITTIQKAQQQRVE RFMFEGVEIPLVPSCAVFTT 
DEFNRINIEVLSWAHQILCILSALAAGLT HFHFDGFEINLVWSCG . . . . 
DEFNRIELEVLS WAQQILCIQRAIQQKLV VFVFEGTELKLNPNCFVAIT 
DEFNRLEESVLSAVSMQIQTIQDALKNHRT-
DEF 
DEFN 
DEFN 
DEFN 
-VCELLGKEVEVNSNSGIFIT 
Fig. 2. Alignment of the deduced amino acid sequences of the cloned human dynein heavy chains with other members of the human DHC 
family. The underlined amino acid residues mark the locations of introns. Primer sets used to generate the amplification products are indicated 
in square brackets. Sequence references are indicated in parentheses. Asterisks indicate clones that have been previously described. 
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3.4. Construction of a phylogenetic tree 
We aligned the deduced amino acid sequences of the yeast 
cytoplasmic DHC [28], thirteen sea urchin DHCs [17] and 
thirteen rat DHCs [20,24] with all cloned human DHCs, i.e. 
two cytoplasmic DHCs (Dnchcl and Dnchc2, [20,36]), six 
axonemal DHCs just recently reported (Dnahcl, Dnahc3, 
Dnahc5, Dnahc6, Dnahc9 and Dnahcl4, [20]) and the three 
new DHC products cloned in this study (Dnahc2, Dnahc3-b 
and Dnahcl 1). To integrate the human DHC genes into an 
evolutionary approach, we used this alignment to generate a 
phylogenetic tree with the neighbor-joining method (Fig. 3). 
According to previous studies [14,17,18], phylogenetic data 
indicate that DHC sequences can be divided into two main 
groups, the cytoplasmic and axonemal DHCs. The former 
consists of two subtypes (Dnchcl and Dnchc2 in humans), 
while the latter contains outer and inner dynein arm DHCs. 
All the human DHC genes identified in this study fit into one 
of these subgroups. Dnchcl belongs to the cytoplasmic DHC 
group, Dnahcl 1 to the axonemal outer dynein arm DHC 
group, and Dnahcl, Dnahc2, Dnahc3 and Dnahc3-b to the 
putative axonemal inner dynein arm DHC group. 
3.5. Tissue distribution of human DHCs 
The expression of the six identified DHC genes was ana-
lysed in various human tissues by means of reverse-transcrip-
tion PCR on total RNA from trachea, testis, liver and lung. 
Dnchc Dnahcl 1 
urchin DHC3b 
human Dnahc5 
rat dlp5 
— sea urchin DHC3a 
^
human Dnahc9 
sea urchin DHC2 
rat dlp9 
r human Dnahcl 1 
'—rat dip 11 
ri5 
rat dlp3 
human Dnahc3-b 
sea urchin DHC7h 
sea urchin DHC7a 
rat dlp7 
human Dnahc3 
rat dip 12 
sea urchin DHC7c 
urchin DHC6 
human Dnahcl 
rat dip! 
"L-hur 
I— c 
J Lhurr 
sea urchin DHC5a 
rat dlp6 
human Dnahcfi 
sea urchin DHC5b 
human Dnahcl4 
I sea urchin DHC4 
I rat dip 10 
rat dlp2 
h man Dnahc2 
sea urchin DHC5c 
yeast CyDn 
-q 
-seaurchin DHCla 
j human Dnchcl 
'rat CyDn 
— sea urchin DHClb 
rat dlp4 
human Dnchc2 
Fig. 3. Phylogenetic tree of the predictive amino acid sequences in 
the Pl-loop region of DHC genes from humans, rats, sea urchins 
and yeast. The different classes of dynein heavy chain are indicated 
on the left, cytoplasmic DHCs and axonemal DHCs including outer 
and putative inner arm DHCs. The scale indicates the number of 
amino acid differences per residue. The yeast cytoplasmic DHC 
(yeast CyDn) was arbitrarily used to root the tree based on UP-
GMA analysis. 
Dnahc2 Dnahc 1 
270 bp -
250 bp" 
Dnahc3 Dnahc3-b 
294 bp-
150 bp-
lOObp 
Fig. 4. Expression of human DHC genes (Dnchcl, Dnahcl, 
Dnahc2, Dnahc3, Dnahc3-b and Dnahcl 1) in various tissues. The 
figure shows 4% agarose gels loaded with the reverse-transcription 
PCR products specific for each human DHC. Numbers on the left 
indicate the length of the PCR products (which are as expected), 
and numbers on the right indicate the length of the 100-bp ladder 
(Life Technologies). Lanes: 1, trachea; 2, testis; 3, liver; 4, lung. 
The integrity of RNAs was checked using an RT-PCR run 
performed with a primer set specific for p^microglobulin (data 
not shown). Three independent experiments revealed that the 
DHC genes are mainly expressed in specific tissues. The 
Dnchcl gene is expressed in all tested tissues, a result in agree-
ment with the ubiquitous expression of DHCs belonging to 
the cytoplasmic group; the other DHCs (i.e. Dnahcl, Dnahc2, 
Dnahc3, Dnahc3-b and Dnahcl 1) are mostly expressed in 
trachea and testis (Fig. 4). 
4. Discussion 
We used a molecular approach to identify members of the 
DHC gene family in humans. Biochemical, immunological 
and genetic analyses suggested that cytoplasmic and axonemal 
dyneins are composed of different dynein heavy chains. Re-
cently, molecular genetic studies confirmed this hypothesis by 
the cloning of a DHC multigene family in various species 
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revealing that the DHC gene family contains at least fifteen 
members (two cytoplasmic and thirteen axonemal DHC 
genes). 
To isolate human DHC genes, we first aligned 56 nucleotide 
sequences encoding the PI-loop region from different species 
except the human axonemal DHC sequences that have been 
reported during the course of this study [20]. This sequence 
alignment allowed us to choose seven degenerated or specific 
oligonucleotide primers bracketing this highly conserved re-
gion. As the exonic sequences encoding the Pl-loop of the 
different DHCs are characterized by a very high degree of 
nucleotide conservation, we used genomic DNA as a template 
in the PCR assays to discriminate the different DHC genes 
and to obtain an equal representation of the different DHC 
sequences. Indeed, genomic DNA allowed us to clone poten-
tial intronic sequences that could be used to distinguish the 
different genes. In addition, the use of such a template pre-
cludes any selection bias that could occur with a cDNA tem-
plate. Furthermore, when studying DHC mRNA expression, 
the existence of intronic sequences provides a valuable control 
to ensure (i) the absence of genomic DNA contamination and 
(ii) the detection of mature mRNA transcripts. Using this 
strategy, we identified six human DHC genes. Three clones 
correspond to human DHC just recently reported: a human 
cytoplasmic DHC (Dnchcl) and two axonemal DHCs 
(Dnahcl and Dnahc3) [20,26,36]. The remaining three clones 
(i.e. Dnahc2, Dnahc3-b and Dnahcl 1) identified new human 
axonemal DHC sequences. In summary, our results raise the 
number of known human DHC sequences to eleven, among 
which two are cytoplasmic whereas nine belong to the axone-
mal DHC group. 
We constructed a phylogenetic tree with sea urchin, rat and 
human DHC sequences. We did not integrate the rat Dnahcl3 
sequence reported by Vaughan et al. [20] in this phylogenetic 
analysis, as careful examination of the corresponding nucleo-
tide sequence revealed that it is identical to the rat DLP1 
cDNA sequence isolated by Tanaka et al. [18], except for a 
106-bp deletion that probably reveals the existence of an alter-
natively spliced exon. Such a hypothesis is further supported 
by the presence, in the genomic sequence encoding human 
Dnahcl (homologous to rat DLP1), of splice consensus se-
quences that flank this 106-bp region (the sequences of accep-
tor and donor splice sites are ACTCAG and GTGAGC, re-
spectively). As expected, in the human Dnahcl clone, this 
exon splicing event would results in a frameshift leading to 
a premature stop codon 23 residues downstream of the 106-bp 
exon; and, if translated, this mRNA would lead to the syn-
thesis of a new DHC protein whose physiological significance 
is unknown. 
According to previous studies, distribution of sequences 
along the tree indicated that DHCs form three main clusters, 
i.e. cytoplasmic DHCs and axonemal outer and inner arm 
DHCs. Different subgroups can be distinguished among the 
outer and inner dynein arm DHCs, as previously described 
[14,17,18,37]. According to this DHC distribution, the Dnchcl 
and Dnchc2 genes encode cytoplasmic DHCs; the Dnahc5, 
Dnahc9 and Dnahcl 1 genes are members of the outer dynein 
arm DHC group, whereas the Dnahcl, Dnahc2, Dnahc3, 
Dnahc3-b, Dnahc6 and Dnahcl4 genes belong to the inner 
dynein arm DHC group. Considering species representation in 
each subgroup, we speculate that there are at least two cyto-
plasmic DHCs, four axonemal outer arm DHCs and nine 
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axonemal inner arm DHCs in mammals, raising the number 
of mammalian DHC genes to at least fifteen. This speculation 
is also supported by recent data obtained in Chlamydomonas 
[14]. Therefore, it is highly likely that at least three human 
axonemal DHC genes remain to be found (one outer and two 
inner arm DHCs). 
It appeared that the human DHC genes were spread 
throughout the genome, Dnchcl and Dnahc2 being located 
on chromosome 14 and 17, respectively, whereas the Dnahcl 
and Dnahc3 genes are located on the same chromosome 
(chromosome 3). The chromosomal location of Dnahc2 (chro-
mosome 17) is in agreement with that of its rat counterpart on 
a mouse chromosomal region which is syntenic to human 
chromosome 17 [20]. Similarly, Dnahcl and Dnahc3 genes 
have been located on mouse chromosome 14 [20] in a region 
syntenic to human chromosome 3p21-pl4, a result consistent 
with our human chromosomal assignment results. In addition, 
we mapped Dnahcl 1 to human chromosome 7. The double 
location of Dnahc3-b on human chromosome 14 and 16 sug-
gests the existence of two axonemal DHC genes homologous. 
Such gene spreading could be due to early duplications of a 
common ancestral DHC gene, as suggested by phylogenetic 
analysis [37]. 
We also analysed the tissue expression of the six human 
DHCs identified in this study. These experiments showed 
that all products except one are mainly expressed in trachea 
and/or testis, while the remaining one (Dnchcl) is expressed in 
all the tissues tested (trachea, testis, liver and lung). The ex-
pression of Dnahcl, Dnahc2, Dnahc3, Dnahc3-b and 
Dnahcl 1, is stronger in trachea and testis (two tissues con-
taining axonemal structures) than in other tested tissues. 
These expression patterns are therefore in agreement with 
the phylogenetic data that are based on sequence analysis 
and support the fact that the Dnchcl gene encodes a cyto-
plasmic DHC, while the Dnahcl, Dnahc2, Dnahc3, Dnahc3-b 
and Dnahcl 1 genes encode axonemal DHCs. 
Finally, the present results will serve to test the potential 
involvement of DHC genes in the primary ciliary dyskinesia 
phenotypes documented in humans. 
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